NEKTAR THERAPEUTICS - NKTR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Two Seas Capital LP | 9.1% | 3,092,234 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Two Seas Capital GP LLC | 9.1% | 3,092,234 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Sina Toussi | 9.1% | 3,092,234 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 3.7% | 1,251,654 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 3.7% | 1,251,654 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 2.8% | 945,732 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 2.8% | 945,732 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.5% | 157,488 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.5% | 157,488 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 6.5% | 2,197,386 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 7.1% | 2,391,075 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF INC/IL | 7.1% | 2,391,075 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 7.1% | 2,391,075 | View |
| Jul 31, 2026 | SCHEDULE 13G | Vanguard Capital Management | 5.17% | 1,747,653 | View |
| Jul 29, 2026 | SCHEDULE 13G | BlackRock, Inc. | 7.8% | 2,643,796 | View |
| May 15, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 5.3% | 1,523,980 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 5.3% | 1,523,980 | View |
| May 15, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 3.9% | 1,114,072 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 3.9% | 1,114,072 | View |
| May 15, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.6% | 171,769 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.6% | 171,769 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 9.1% | 2,638,052 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 9.8% | 2,852,698 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF INC/IL | 9.8% | 2,852,698 | View |
| May 15, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 9.8% | 2,852,698 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 15.0% | 4,303,188 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 15.0% | 4,303,188 | View |
| Apr 17, 2026 | SCHEDULE 13G | Two Seas Capital LP | 6.8% | 1,959,178 | View |
| Apr 17, 2026 | SCHEDULE 13G | Two Seas Capital GP LLC | 6.8% | 1,959,178 | View |
| Apr 17, 2026 | SCHEDULE 13G | Sina Toussi | 6.8% | 1,959,178 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.